Stephens Investment Management Group LLC Makes New $13.20 Million Investment in Astera Labs, Inc. $ALAB

Stephens Investment Management Group LLC bought a new position in Astera Labs, Inc. (NASDAQ:ALAB) during the 3rd quarter, Holdings Channel reports. The fund bought 67,423 shares of the company’s stock, valued at approximately $13,201,000.

A number of other hedge funds also recently made changes to their positions in the company. Vanguard Group Inc. increased its stake in Astera Labs by 29.6% in the 2nd quarter. Vanguard Group Inc. now owns 12,049,223 shares of the company’s stock worth $1,089,491,000 after acquiring an additional 2,751,747 shares during the last quarter. FengHe Fund Management Pte. Ltd. bought a new position in shares of Astera Labs during the 2nd quarter valued at approximately $106,772,000. 1832 Asset Management L.P. grew its holdings in shares of Astera Labs by 151.4% in the second quarter. 1832 Asset Management L.P. now owns 1,543,500 shares of the company’s stock valued at $139,563,000 after purchasing an additional 929,600 shares in the last quarter. Holocene Advisors LP bought a new stake in Astera Labs in the second quarter worth $55,827,000. Finally, State Street Corp increased its position in Astera Labs by 39.3% in the second quarter. State Street Corp now owns 2,143,459 shares of the company’s stock worth $193,812,000 after purchasing an additional 604,363 shares during the last quarter. 60.47% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In other Astera Labs news, COO Sanjay Gajendra sold 90,459 shares of Astera Labs stock in a transaction on Monday, November 17th. The stock was sold at an average price of $144.69, for a total transaction of $13,088,512.71. Following the completion of the sale, the chief operating officer directly owned 1,599,750 shares of the company’s stock, valued at $231,467,827.50. The trade was a 5.35% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, General Counsel Philip Mazzara sold 4,620 shares of the company’s stock in a transaction on Monday, November 17th. The stock was sold at an average price of $144.69, for a total value of $668,467.80. Following the completion of the sale, the general counsel owned 147,040 shares of the company’s stock, valued at $21,275,217.60. This represents a 3.05% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last ninety days, insiders have sold 576,936 shares of company stock valued at $87,409,540. Insiders own 12.50% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have commented on ALAB. Northland Securities lifted their price objective on shares of Astera Labs from $175.00 to $195.00 and gave the stock an “outperform” rating in a research note on Tuesday, December 9th. Raymond James Financial began coverage on Astera Labs in a research note on Friday, November 21st. They set a “hold” rating on the stock. Cowen restated a “hold” rating on shares of Astera Labs in a research report on Wednesday, November 5th. Wall Street Zen cut Astera Labs from a “buy” rating to a “hold” rating in a report on Tuesday, November 11th. Finally, Citigroup reissued an “outperform” rating on shares of Astera Labs in a research report on Tuesday, December 9th. One investment analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and eight have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $190.63.

Astera Labs Stock Performance

Shares of NASDAQ ALAB opened at $182.00 on Friday. The business’s 50 day moving average price is $159.80 and its 200-day moving average price is $166.29. Astera Labs, Inc. has a fifty-two week low of $47.13 and a fifty-two week high of $262.90. The company has a market cap of $30.74 billion, a price-to-earnings ratio of 163.96, a PEG ratio of 2.48 and a beta of 1.50.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings data on Tuesday, November 4th. The company reported $0.49 EPS for the quarter, beating the consensus estimate of $0.39 by $0.10. Astera Labs had a return on equity of 13.48% and a net margin of 27.50%.The company had revenue of $230.58 million for the quarter, compared to the consensus estimate of $206.42 million. During the same quarter in the prior year, the company posted $0.23 EPS. Astera Labs’s quarterly revenue was up 103.9% on a year-over-year basis. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. Sell-side analysts predict that Astera Labs, Inc. will post 0.34 earnings per share for the current year.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.